Pharmavox SRL
The score of Pharmavox shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2026
Change 2023 → 2026: Equity -14 % Total assets -20 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmavox's annual accounts
Filed annual accounts
- Year ended 31 Mar 2026filed on 16 Oct 2026
- Year ended 31 Mar 2025filed on 28 Oct 2025
- Year ended 31 Mar 2024filed on 29 Oct 2024
- Year ended 31 Mar 2023filed on 31 Oct 2023
- Year ended 31 Mar 2022filed on 10 Oct 2022
Pharmavox's financial analysis
- Solvency60.8%sector median: 54.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmavox
Pharmavox's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0841.606.444
- VAT number
- BE0841606444
- Peppol
- Registered · 0208:0841606444 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 07 Dec 2011
- Registered office
- 1170 Watermael-Boitsfort
- Latest accounts
- 2026 · filed on 16 Oct 2026
- Activity
- Other business support service activities n.e.c. (NACE 82990)
Pharmavox (SRL) has been based in Watermael-Boitsfort since 2011, active in: other business support service activities n.e.c.. For 2026, it reports a net loss of 475,741 € and equity of €6.40m; its revenue is not published. Its solvency stands at 60.8%, above the median of its sector (54.1%).
Companies similar to Pharmavox
Companies in the same business, of comparable size and area, outside its group.
- MGL Consulting Business and other management consultancy activities Enghien · balance sheet €10.5m
- V-MAT Consulting Business and other management consultancy activities Ath · balance sheet €10.5m
- Cortexco Business and other management consultancy activities Roeselare · balance sheet €11.4m
- ZISK Business and other management consultancy activities Zele · balance sheet €8.82m
- Sindbad Management Business and other management consultancy activities Uccle · balance sheet €8.72m
- Kordan Business and other management consultancy activities Kortrijk · balance sheet €14.3m
- Hof Beheer Business and other management consultancy activities Hoogstraten · balance sheet €15.7m
- Mobiman Business and other management consultancy activities Kapelle-op-den-Bos · balance sheet €13.4m
Frequently asked questions about Pharmavox
What is the revenue of Pharmavox?
Pharmavox files its accounts in a format where revenue is optional: it is not published for 2026.
What is the VAT number of Pharmavox?
In Belgium, the VAT number is the company number prefixed with BE: BE0841606444 for Pharmavox, if the company is VAT-registered. Its company number (CBE) is 0841.606.444.
Where is the registered office of Pharmavox?
According to the CBE register, the registered office of Pharmavox is in 1170 Watermael-Boitsfort.
What is the equity of Pharmavox?
At the close of the 2026 financial year, the equity of Pharmavox amounts to 6,404,971 €, a solvency of 60.8% of total assets.
Who manages Pharmavox?
The register lists 5 active mandates at Pharmavox. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmavox
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →